According to Madrigal Pharmaceuticals 's latest financial reports the company's total liabilities are $0.23 B. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2023-12-31 | $0.23 B | 42.4% |
2022-12-31 | $0.16 B | 113.9% |
2021-12-31 | $77.22 M | 64.22% |
2020-12-31 | $47.02 M | 84.48% |
2019-12-31 | $25.49 M | 201.88% |
2018-12-31 | $8.44 M | -16.01% |
2017-12-31 | $10.05 M | 109.46% |
2016-12-31 | $4.8 M | -90.26% |
2015-12-31 | $49.27 M | 38.66% |
2014-12-31 | $35.53 M | -22.93% |
2013-12-31 | $46.11 M | 64.97% |
2012-12-31 | $27.95 M | 1.46% |
2011-12-31 | $27.55 M | -9.93% |
2010-12-31 | $30.58 M | 27.46% |
2009-12-31 | $23.99 M | -84.62% |
2008-12-31 | $0.15 B | 59.63% |
2007-12-31 | $97.75 M | 72.9% |
2006-12-31 | $56.53 M | 201.8% |
2005-12-31 | $18.73 M | 33.21% |
2004-12-31 | $14.06 M | 302.26% |
2003-12-31 | $3.49 M | |
2001-12-31 | $0.02 M |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $0.62 B | 164.64% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | $12.01 M | -94.89% | ๐บ๐ธ USA |